Background: Carotid blowout syndrome (CBS) is a life-threatening complication of head and neck cancer and radiation therapy. Endovascular techniques have emerged as preferable alternatives to surgical ligation for treatment of CBS. We performed a systematic review and meta-analysis to study periprocedural complications and outcomes of CBS patients treated with coil embolization and covered stents.
Carotid blowout syndrome (CBS), or the rupture of the common carotid artery and its branches, is a lifethreatening complication of head and neck cancer and radiation therapy. When it is treated surgically, CBS is associated with neurologic morbidity and mortality rates of up to 60% and 40%, respectively.
1,2 Endovascular techniques such as coil embolization and stent grafting offer an alternative to surgical ligation with better patient outcomes. 3, 4 Still, morbidity and mortality remain high. 5 To our knowledge, there has been no systematic analysis of different endovascular techniques in treating CBS with respect to complications and outcomes. We performed a systematic review and meta-analysis to study perioperative complications and outcomes of CBS patients treated with deconstructive techniques (ie, coils) and reconstructive techniques (ie, covered stent grafts).
METHODS
Literature search and inclusion criteria. This systematic review and meta-analysis conforms to the Preferred Reporting Items for Systematic Reviews and MetaAnalyses (PRISMA) guidelines. A comprehensive literature search of PubMed, Ovid MEDLINE, and Ovid Embase was performed for studies published from 2000 to April 2016. The search used the following keywords: "carotid blowout," "covered stent," "stent," "carotid sacrifice," and "coiling" in both "AND" and "OR" combinations. The inclusion criteria were the following: (1) consecutive series of three or more patients who were treated for carotid blowout with coil embolization or covered stent grafts and (2) studies that reported perioperative complications or patient outcomes. Exclusion criteria were the following: (1) fewer than three patients in the series; (2) no report of perioperative complications or patient outcomes; and (3) studies in which an English translation was not available. Two independent reviewers determined whether the articles met the criteria for inclusion in this systematic review and meta-analysis.
Data extraction. The following baseline information was extracted from each study: number of patients, mean age, gender distribution, location, rupture status, and follow-up duration. The following outcomes were examined: technical success, postoperative rebleeding, survival time, and percentage of patients alive at last follow-up. Technical success is defined as successful device deployment with control of bleeding. Perioperative (<30 days) complications, including infection, stroke, and mortality, were also evaluated. If the same patient was included in more than one study, only data from the article with the longest follow-up were included. Risk of bias assessment. Risk of bias was assessed using a modification of the Newcastle-Ottawa score. Studies were assessed on the basis of selection criteria and ascertainment of outcomes. Selection criteria were determined by the adequacy of case definitions and representativeness of the cases (eg, consecutive case series, definition of CBS clearly defined, and location of CBS clearly defined). Factors considered in ascertainment of outcomes included uniform clinical and imaging follow-up, clearly defined outcomes, and study design (ie, retrospective chart review vs prospective study with predefined end points).
Statistical analysis. The cumulative incidence and 95% confidence interval (CI) were estimated for each outcome. In anticipation of heterogeneity both within and between studies, a random-effects model was used to pool incidence rates across studies. 6 Variance was estimated using the Freeman-Tukey double arcsine method. 7, 8 I 2 values were computed to express the proportion of inconsistency not attributable to chance. 9 Analyses were conducted using the Stata Statistical Software release 14 (StataCorp LP, College Station, Tex).
RESULTS
Literature search. The literature search yielded 245 studies, of which 149 were excluded after reading of the title and abstract. Thirty-two studies were excluded for not having a full-text version, review articles, or duplicates. Of the remaining 64 full-text articles, 39 did not treat CBS with endovascular techniques, did not meet our minimum sample size criterion of three patients, or did not report periprocedural complications or patient outcomes. Twenty-five studies met all criteria and were included in the meta-analysis. A summary of these studies is provided in Table I . The PRISMA flow diagram is provided in Fig. Patient demographics. There were 559 patients (471 men and 88 women) with CBS included in this study; 287 presented with an acute bleed and 272 had threatened or impending bleeding, which was defined as a large pseudoaneurysm. In 131 patients, CBS involved the internal carotid artery; in 218, the external carotid artery; and in 208, the common carotid artery. There were 295 cases of CBS treated with coil embolization, 197 with covered stent grafts, and 75 with an alternative technique. Alternative techniques included surgical ligation in 13 cases, balloon occlusion in 12, n-butyl cyanoacrylate (NBCA) glue in 10, Pipeline (Covidien, Mansfield, Mass) embolization in 8, and combinations of balloons and coils and NBCA glue in 30.
STUDY OUTCOMES
Patient outcomes and perioperative complications are summarized in Table II . Technical success rate was 100% in both the coiling (95% CI, 100%-100%) and stent grafting (95% CI, 98%-100%) groups (P ¼ 1). Rebleeding rate was 27% (95% CI, 19%-36%) among all patients, 17% (95% CI, 5%-33%) for patients treated with coils, and 34% (95% CI, 24%-44%) for patients treated with covered stents (P ¼ .07). One percent of all patients had a perioperative infection (95% CI, 0%-5%). Perioperative mortality was 11% for all patients (95% CI, 5%-17%), 3% (95% CI, 0%-14%) for those treated with coiling, and 12% (95% CI, 5%-21%) for those treated with covered stents (P ¼ .25). The overall rate of perioperative stroke was 3% (95% CI, 1%-6%). Perioperative stroke rate was 1% for both coiling and stenting groups (1% [95% CI, 0%-5%] vs 1% [95% CI, 0%-5%]; P ¼ .81). Mean postprocedural survival time was 9.8 months (95% CI, 7.1-12.5) for all patients, 10.7 months for those treated with coils (95% CI, 7.5-13.9), and 6.5 months for those treated with covered stents (95% CI, 4.2-8.7). Of the studies that reported follow-up data on individual patients, median survival time was 3 months and interquartile range was 9.5 months. Of all CBS patients treated with endovascular techniques, 39% were alive at last follow-up (95% CI, 29%-48%); 27% of patients treated with coiling (95% CI, 18%-36%) and 40% of patients treated with stenting (95% CI, 23%-58%) were alive at last follow-up (P ¼ .04).
Study heterogeneity and risk of bias. I 2 values were $50% for 7 of 19 outcomes, indicating substantial heterogeneity. Six outcomes had I 2 values of 0, indicating little heterogeneity between studies. Of the 25 studies included in this meta-analysis, 24 were retrospective and 1 was prospective. All studies were found to have a high risk of bias based on study design, lack of imaging, and short clinical follow-up length. It was not possible to evaluate the presence of publication bias because of the noncomparative nature of the available studies.
DISCUSSION
This systematic review and meta-analysis demonstrated that coil embolization and stenting may be safe treatment options for CBS. Both techniques were associated with high rates of technical success and low perioperative complication rates. Despite this, patients survived an average of 10 months after treatment, and only 39% of patients were alive at last follow-up. In addition, more than one in four patients experienced rebleeding after treatment. These findings are important as they highlight the importance of providing a durable treatment option to CBS patients, but they also outline that CBS is often a clinical manifestation of a disease in its late stages. One of the most commonly reported complications of endovascular occlusion, whether it is with detachable balloons, coiling, NBCA, or particles, is delayed cerebral ischemia. 2, 3 Balloon test occlusion is used to identify patients at risk of immediate ischemic complications. However, the incidence of delayed ischemic events in patients who passed the balloon test occlusion has been reported to be as high as 20%. 2 Therefore, patients who have an incomplete circle of Willis or delayed occlusion of a collateral blood vessel are at risk for irreversible neurologic complications. The ischemic risks associated with these deconstructive techniques provided an indication for alternative, reconstructive management strategies.
Reconstructive treatments (ie, stent grafting) allow the preservation of blood flow through the carotid artery and artificially reinforce the vessel wall, thereby lowering the risk for ischemic complications. However, these techniques pose a risk for acute thromboembolism due to the inherently thrombogenic nature of stents. 3, 10, 11 As such, antiplatelet therapy must be initiated when CBS patients are treated reconstructively to prevent in-stent thrombosis. Because patients with CBS are often suffering from head and neck cancer and sequelae from chemotherapy, it is necessary to consider how such a prolonged antiplatelet regimen would affect the clinical course of their other conditions. It is important to review each patient's case on an individual basis, taking into consideration each technique's associated risks while trying to meet the patient's treatment goals. Chang et al were the first to compare patient outcomes after reconstructive and deconstructive techniques in a case series of 24 CBS patients. 12 It was retrospectively determined that all cases included in the study could have been treated with either approach. All cases achieved technical success, and there were no differences in perioperative complications or outcomes between groups. The authors suggested that outcomes were predicted by clinical severity at presentation, not by treatment type. Although no direct comparison between reconstructive and deconstructive techniques could be made in our study because of the lack of sufficient baseline data, we did not find any substantial differences between reconstructive (stenting) and deconstructive (coiling) treatment modalities aside from survival time.
Stent grafting is a newer treatment option for CBS than coil embolization. As such, case series are typically able to report longer follow-up for patients treated with coiling than with covered stents. This may be a large factor in the statistically greater survival time in those patients treated with coiling.
One of the most interesting findings from this metaanalysis is the length of patients' postoperative survival time. Because of the severity and acute onset of CBS, treatment has classically been thought of as extremely limited and palliative. 13, 14 The urgency required in controlling massive hemorrhage coupled with the exposed nature of the wound has commonly forced treatment in contaminated and infected fields. These operative conditions have on occasion led to sepsis, brain abscesses, and ultimately death. 2, 10, 13, 15 Even when treatment is technically successful with no complications, patients typically continue to suffer from head and neck cancer. Despite these challenges, endovascular treatment modalities were able to afford patients an average of 10 extra months of survival.
Patients treated with coiling did appear to survive longer than those treated with covered stents. However, this may be due to the fact that coiling is more commonly used to treat external carotid artery blowout, which is less life-threatening than blowout of the common carotid artery or internal carotid artery. Despite the poor prognosis of CBS patients, some survive for 1 year or longer. As such, all treatment devices must be durable and designed with the intention of lasting for the duration of these patients' lifetimes. In addition, special care must be taken to avoid contamination of the implanted devices, and patients must continue to be monitored for infectious complications long after treatment.
Limitations. This systematic review has limitations. The majority of studies included in our meta-analysis were retrospective, nonrandomized, and noncomparative. As a result, there is a large variability in methods both within and between studies, and outcomes were inconsistently reported. In general, treatment decisions for patients included in our analysis were made on a case-by-case basis, and it is impossible to determine whether the baseline characteristics of patients undergoing deconstructive techniques were similar to those of patients undergoing reconstructive techniques (eg, age, stage of cancer, type of vessel involved, presence of collaterals, and tolerance of test balloon occlusion). Articles generally did not report whether cases of threatened or impending bleeding were treated electively. In addition, this body of evidence likely suffers from publication bias, as retrospective studies have a tendency to publish positive results and accounts of technically successful cases.
CONCLUSIONS
This systematic review and meta-analysis demonstrated that both coil embolization and stent grafting are likely to be viable treatment options for CBS. Both techniques have low perioperative complication rates and high rates of technical success. Coiling and stent grafting are safe alternatives to surgical ligation for treatment of CBS, but prognosis after treatment is poor. Although prospective studies may be difficult to perform, given the rarity and acute onset of CBS, uniform methods and reporting of outcomes would be needed to confirm these results. 
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